Pharmafile Logo
Pharmafocus logo
Advanced Search

five prime

Showing 3 posts of 3 posts found.

amgen_flag

Amgen to acquire Five Prime Therapeutics for approximately $1.9bn

March 5, 2021
Medical Communications Amgen, Cancer, five prime

Amgen has announced it will acquire Five Prime Therapeutics for $38.00 per share in cash, representing an equity value of …

News
T-cell

$350m collaboration deal for BMS and Five Prime Therapeutics

October 15, 2015
Research and Development BMS, Bristol-Myers Squibb, R&D, five prime, immuno-oncology, tumours

Bristol-Myers Squibb has signed a collaboration agreement with the US biotech firm Five Prime Therapeutics, for a Colony Stimulating Factor …

News
BMS image

BMS hopes for Yervoy sequel with new deal

March 18, 2014
Research and Development, Sales and Marketing Avapro, BMS, Plavix, Yervoy, five prime, immune-oncology

Bristol-Myers Squibb has announced a new research and development deal with Five Prime Therapeutics aimed at discovering potentially new cancer …

News

Latest content

Prism BioLab and Ono Pharmaceutical enter joint research and licensing agreement

April 25, 2024

Ascendis Pharma’s Yorvipath approved by MHRA for hypoparathyroidism treatment

April 25, 2024

Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals

April 24, 2024

GSK’s Jemperli accepted for FDA review for endometrial cancer treatment

April 24, 2024

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024